Astera Labs, Inc. (NASDAQ:ALAB) Shares Purchased by Pier Capital LLC

Pier Capital LLC boosted its holdings in Astera Labs, Inc. (NASDAQ:ALABFree Report) by 187.2% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 82,916 shares of the company’s stock after acquiring an additional 54,048 shares during the period. Pier Capital LLC owned about 0.05% of Astera Labs worth $4,344,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Astera Labs during the 3rd quarter worth approximately $530,000. Avior Wealth Management LLC bought a new position in Astera Labs during the 3rd quarter worth $361,000. Meeder Asset Management Inc. acquired a new stake in Astera Labs in the third quarter worth $1,141,000. Bank of Hawaii bought a new stake in Astera Labs in the third quarter valued at $1,409,000. Finally, Maverick Capital Ltd. lifted its stake in Astera Labs by 16.0% in the third quarter. Maverick Capital Ltd. now owns 1,156,230 shares of the company’s stock valued at $60,575,000 after buying an additional 159,480 shares during the last quarter.

Analyst Ratings Changes

ALAB has been the topic of a number of analyst reports. Roth Mkm increased their price objective on shares of Astera Labs from $80.00 to $105.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Stifel Nicolaus raised their price target on shares of Astera Labs from $80.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft boosted their price objective on Astera Labs from $60.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. Needham & Company LLC restated a “buy” rating and issued a $65.00 target price on shares of Astera Labs in a research report on Wednesday, October 9th. Finally, Barclays boosted their price target on Astera Labs from $70.00 to $87.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Twelve investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $94.67.

Read Our Latest Research Report on ALAB

Insider Buying and Selling

In other Astera Labs news, Director Manuel Alba sold 11,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $117.50, for a total value of $1,292,500.00. Following the transaction, the director now owns 456,863 shares in the company, valued at approximately $53,681,402.50. The trade was a 2.35 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO Michael Truett Tate sold 16,000 shares of the stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $117.84, for a total value of $1,885,440.00. Following the sale, the chief financial officer now owns 1,412,888 shares of the company’s stock, valued at $166,494,721.92. This trade represents a 1.12 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 2,154,820 shares of company stock worth $195,106,438 in the last ninety days.

Astera Labs Price Performance

ALAB opened at $120.40 on Friday. The stock’s fifty day moving average is $81.38 and its 200-day moving average is $62.40. Astera Labs, Inc. has a one year low of $36.22 and a one year high of $121.20.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.23 EPS for the quarter, topping the consensus estimate of $0.17 by $0.06. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. The firm had revenue of $113.10 million for the quarter, compared to analysts’ expectations of $97.50 million. Astera Labs’s revenue for the quarter was up 47.1% on a year-over-year basis. As a group, equities research analysts predict that Astera Labs, Inc. will post -0.45 earnings per share for the current fiscal year.

Astera Labs Profile

(Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Featured Articles

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.